The global success of mRNA medicines would not have succeeded without comprehensive analytical support. With more pressure on drug development timelines, the necessity to access novel, optimised and high-throughput analytical methods is paramount to guarantee the approval & commercialisation of safe and efficacious mRNA therapeutics and vaccines.
Industry experts navigated through case-study-led presentations and interactive discussions to:
Hot Sessions from 2023:
- Maximise mRNA Characterisation to Ensure Safety, Efficacy & Quality of mRNA Therapeutics & Vaccines
- Overcome Existing Potency & Quality Challenges with Advanced & Accurate Analytical Assays & Techniques
- Understand Standards & Regulatory Requirements for the Analytical Development of mRNA Vaccines for a Rapid Approval